Search Results

Displaying Results 3276-3300 of 26651 "'D'"

Aug 06, 2026, 08:00 ET Only 7% of Therapy Practices Track What They Say Defines Success, New Ensora Health Research Finds

the newly released 2026 Practice Success Report due to the company's strong commitment to helping therapy practices," said ACA CEO Brian D. Banks. "We think this will be a tremendous value-add to our members because we continue to hear from so many of them about how challenging and complex

More news about: Ensora Health


Aug 06, 2026, 08:00 ET Edgewise Therapeutics Reports Second Quarter 2026 Financial Results

CIRRUS-HCM Phase 2 trial in adults with symptomatic HCM: The company announced positive top-line results from the 12-week Phase 2 Part D CIRRUS-HCM open label trial of EDG-7500 in obstructive (oHCM) and nonobstructive (nHCM) HCM, which was designed to inform a Phase 3 trial. Results from

More news about: Edgewise Therapeutics


Aug 06, 2026, 08:00 ET ONCOR REPORTS SECOND QUARTER 2026 RESULTS

updated interim rates to reflect increases in invested capital, and customer growth. Financial and operational results are provided in Tables A, B, C, D, and E below.

More news about: Oncor Electric Delivery Company LLC


Aug 06, 2026, 07:58 ET IQST - IQSTEL Expects to Surpass an $8 Million Adjusted EBITDA Run Rate This Quarter as It Leverages Its Global Platform to Accelerate Growth

portfolio of proprietary Digital Services through its internal research and development organization, led by Jose Enrique Puente, Head of AI & R&D. As highlighted during the Company's recent Force Family Office Webinar, these technologies include Artificial Intelligence platforms, AI Voice Agents,

More news about: iQSTEL


Aug 06, 2026, 07:55 ET Sempra Reports Strong Second-Quarter 2026 Results

SEMPRATable D

More news about: Sempra


Aug 06, 2026, 07:30 ET Suburban Propane Partners, L.P. Announces Third Quarter Results

compared to the prior year, while revenues from RNG injection benefited from higher prices for environmental attributes, including California LCFS and D3 RIN credits. Subsequent to the end of the quarter, we placed our new anaerobic digester facility in Upstate New York into service, and expect to place

More news about: Suburban Propane Partners, L.P.


Aug 06, 2026, 07:30 ET Cars.com Reports Second Quarter 2026 Results

properties (responsive sites and mobile apps). The Company measures UVs and Traffic via RudderStack. These metrics do not include traffic to Dealer Inspire, D2C Media, or DealerClub websites.Monthly Average Revenue Per Dealer ("ARPD"). The Company believes that its ability to grow ARPD is an indicator

More news about: Cars.com Inc.


Aug 06, 2026, 07:30 ET ATI Announces Second Quarter 2026 Results

productivity improvements, synergies, growth or other benefits anticipated by management from strategic investments and the integration of acquired businesses; (d) volatility in the price and availability of the raw materials that are critical to the manufacture of our products; (e) declines in the value of our

More news about: ATI


Aug 06, 2026, 07:05 ET Arbe Appoints Assaf Pereg, CPA, as Chief Financial Officer

and the Israeli shekel; and the risks and uncertainties described in "Cautionary Note Regarding Forward-Looking Statements," "Item 3. Key Information – D. Risk Factors" and "Item 5. Operating and Financial Review and Prospects" and in the Company's Annual Report on Form 20-F for the year ended December

More news about: Arbe Robotics


Aug 06, 2026, 07:05 ET REGENXBIO Reports Second Quarter 2026 Financial Results and Operational Highlights

certain net sales of ITVISMA in the U.S. and other jurisdictions with patents extending until 2037.Research and Development (R&D) Expenses: R&D expenses were $56.1 million for the three months ended June 30, 2026, compared to $59.5 million for the three months ended June 30, 2025.

More news about: REGENXBIO Inc.


Aug 06, 2026, 07:00 ET Hadrian Raises $1.37B Series D to Build Highly Automated Factories to Accelerate America's Industrial Renewal

The financing will support new factories, expanded R&D, and additional production capabilities as Hadrian builds the industrial infrastructure required to deliver complete mission-critical systems at speed

More news about: Hadrian


Aug 06, 2026, 07:00 ET Mediar Therapeutics Enters into a Collaboration and Option Agreement with Ono Pharma to Develop Novel Treatments for Fibro-inflammatory Diseases

have an exclusive option to license worldwide rights to develop and commercialize the programs, making an upfront payment to Mediar, and supporting R&D costs."This strategic collaboration with Ono is an important milestone for Mediar and reflects the growing recognition that directly targeting

More news about: Mediar Therapeutics


Aug 06, 2026, 07:00 ET Howmet Aerospace Reports Second Quarter 2026 Results

information technology or data security breaches; (c) the loss of significant customers or adverse changes in customers' business or financial conditions; (d) manufacturing difficulties or other issues that impact product performance, quality or safety; (e) inability of suppliers to meet obligations due to

More news about: Howmet Aerospace Inc.


Aug 06, 2026, 07:00 ET Arbe Announces Second Quarter 2026 Financial Results

and the Israeli shekel; and the risks and uncertainties described in "Cautionary Note Regarding Forward-Looking Statements," "Item 3. Key Information – D. Risk Factors" and "Item 5. Operating and Financial Review and Prospects" and in the Company's Annual Report on Form 20-F for the year ended December

More news about: Arbe


Aug 06, 2026, 07:00 ET Insmed Reports Second-Quarter 2026 Financial Results and Provides Business Update

lower manufacturing costs than ARIKAYCE.Research and development (R&D) expenses were $210.0 million for the second quarter of 2026, compared to $177.2 million for the second quarter of 2025. The increase in R&D expenses for the second quarter of 2026 was primarily related to increases

More news about: Insmed Incorporated


Aug 06, 2026, 06:59 ET Viatris Reports Second-Quarter 2026 Financial Results

ranges as provided on August 6, 2026, exclude the impact of any transaction-related and restructuring-related costs (as defined below) and acquired IPR&D for unsigned deals as they cannot be reasonably forecasted. Please see "2026 Financial Guidance" and "Non-GAAP Financial Measures" for additional

More news about: Viatris Inc.


Aug 06, 2026, 06:58 ET ChainIT and RS Software Form Alliance to Bring Risk-Based Authentication to Account-to-Account Payments

authentication to account-to-account (A2A) payments. Card payments have had a shared framework for authenticating risky transactions for two decades through 3-D Secure. Instant payments, which settle in seconds and cannot be reversed, have never had a comparable industry-wide standard, a gap this alliance is designed

More news about: ChainIT Inc


Aug 06, 2026, 06:30 ET NetEase to Report Second Quarter 2026 Financial Results on August 20

some of the most popular and longest-running mobile and PC games available in China and globally.Powered by one of the largest in-house game R&D teams focused on mobile, PC and console, NetEase creates superior gaming experiences, inspires players, and passionately delivers value for its thriving

More news about: NetEase, Inc.


Aug 06, 2026, 06:00 ET KuCoin Pay mở rộng khả năng ứng dụng của stablecoin với giải pháp thẻ quà tặng dành cho doanh nghiệp

multimedia:https://www.prnewswire.com/vn/news-releases/u006Bu0075u0063u006Fu0069u006Eu002Du0070u0061u0079u002Du006Du1EDFu002Du0072u1ED9u006Eu0067u002Du006Bu0068u1EA3u002Du006Eu0103u006Eu0067u002D-302843000.htmlSOURCE

More news about: KuCoin


Aug 06, 2026, 06:00 ET EPAM Reports Results for Second Quarter 2026

1,194Poland R&D incentives (b)—

More news about: EPAM Systems, Inc.


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.